KoBioLabs, Inc (KOSDAQ: 348150)

KoBioLabs Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	9,692	10,047	10,433	52,693	40,627	1,278
Short-Term Investments	47,937	56,194	82,514	33,989	10,348	31,641
Trading Asset Securities	-	-	-	2,003	-	-
Cash & Short-Term Investments	57,630	66,240	92,947	88,685	50,975	32,920
Cash Growth	-27.41%	-28.73%	4.81%	73.98%	54.84%	295.77%
Accounts Receivable	5,001	1,858	701.91	199.2	2,678	107.91
Other Receivables	1,064	3,020	4,279	3,118	2,475	979.86
Receivables	6,065	4,878	4,991	3,437	5,153	1,088
Inventory	3,274	1,467	977.47	256.21	105.56	122.96
Prepaid Expenses	1,093	1,765	1,852	2,133	1,442	505.82
Other Current Assets	1,729	1,378	1,711	4,108	134.87	18.8
Total Current Assets	69,790	75,729	102,478	98,619	57,810	34,655
Property, Plant & Equipment	32,413	34,858	20,485	5,791	383.21	384.51
Long-Term Investments	2,498	2,484	0	0	-0	-0
Other Intangible Assets	605.02	637.67	279.6	324.2	300.73	270.57
Other Long-Term Assets	1,032	914.62	687.14	541.7	43.32	11.29
Total Assets	106,338	114,623	123,930	105,285	58,537	35,322
Accounts Payable	2.58	-	-	-	-	68.59
Accrued Expenses	1,591	1,127	763.8	543.31	385.63	472.59
Short-Term Debt	3,772	8,633	1,700	-	-	-
Current Portion of Long-Term Debt	3,464	58.36	-	1,515	-	-
Current Portion of Leases	204.16	234.21	136.51	24.6	28.77	33.74
Current Unearned Revenue	814.87	775.09	120.24	632.53	270.89	64.82
Other Current Liabilities	6,066	10,323	6,223	4,124	2,404	80,609
Total Current Liabilities	15,914	21,151	8,944	6,840	3,089	81,248
Long-Term Debt	8,949	9,172	11,765	7,633	-	-
Long-Term Leases	140.44	195.96	180.53	24.37	57.1	72.99
Other Long-Term Liabilities	22,274	22,285	7,586	200	-	4.36
Total Liabilities	47,278	52,804	28,475	14,697	3,146	81,326
Common Stock	9,667	9,436	8,722	8,135	7,759	3,549
Additional Paid-In Capital	215,793	219,114	220,581	208,053	158,760	1,122
Retained Earnings	-165,169	-162,827	-148,975	-127,053	-111,671	-56,599
Comprensive Income & Other	-18,222	-21,022	-3,736	577.08	543	-1,697
Total Common Equity	42,069	44,702	76,592	89,713	55,391	-53,624
Minority Interest	16,883	16,868	18,132	-	-	-
Shareholders' Equity	59,060	61,819	95,455	90,589	55,391	-46,004
Total Liabilities & Equity	106,338	114,623	123,930	105,285	58,537	35,322
Total Debt	16,530	18,294	13,782	9,197	85.87	106.73
Net Cash (Debt)	41,100	47,946	79,165	79,488	50,889	32,813
Net Cash Growth	-35.80%	-39.43%	-0.41%	56.20%	55.09%	294.49%
Net Cash Per Share	2166.10	2587.95	4713.30	4953.80	4747.27	4645.07
Filing Date Shares Outstanding	19.33	18.87	17.44	16.27	15.52	7.1
Total Common Shares Outstanding	19.33	18.87	17.44	16.27	15.52	7.1
Working Capital	53,876	54,578	93,535	91,779	54,721	-46,593
Book Value Per Share	2175.85	2368.65	4390.83	5513.80	3569.33	-7554.15
Tangible Book Value	41,464	44,064	76,312	89,388	55,090	-53,894
Tangible Book Value Per Share	2144.56	2334.86	4374.80	5493.88	3549.95	-7592.26
Land	6,477	6,477	6,477	-	-	-
Buildings	14,271	16,563	5,925	-	-	-
Machinery	10,840	4,569	3,920	859.78	634.9	500.98
Construction In Progress	-	8,766	4,929	5,321	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.